OnabotulinumtoxinA for chronic migraine: Efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program

S. K. Aurora, D. W. Dodick, H. C. Diener, R. E. Degryse, C. C. Turkel, R. B. Lipton, S. D. Silberstein

Research output: Contribution to journal › Article › peer-review

87 Scopus citations

Fingerprint

Dive into the research topics of 'OnabotulinumtoxinA for chronic migraine: Efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program'. Together they form a unique fingerprint.

Medicine & Life Sciences